What is it really like to take your company public via a SPAC? One Boston biotech shares its journey

From PIPEs to SEC rules on disclosure, Ginkgo Bioworks shares their journey navigating the world of SPACs.

Read more→

$12 for 12 Weeks

With a Fortune subscription, you get access to unlimited business and finance news, the latest insights from the top minds in the industry, original video content packed with analysis and learnings, and exclusive interviews with CEOs. 

At just $1/week, it’s the best investment for investors.

MORE FROM THE LATEST INVESTMENT GUIDE

• How Silicon Valley Bank became a pre-IPO play—then became a top-performing stock itself
• How regular investors can access IPOs
• The 2021 IPO market in 4 charts: ‘Record-breaking, on fire, historic, extremely active, very busy’

IT PAYS TO KNOW.